Covenant Health Cancer Centers — Knoxville, Tennessee

Covenant Health Cancer Centers is a clinical research site located in Knoxville, Tennessee, United States 37916.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Covenant Health Cancer Centers has participated in 22 clinical trials with 22 currently active.

Therapeutic areas: Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), NRG Oncology.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Covenant Health Cancer Centers?

Covenant Health Cancer Centers has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Covenant Health Cancer Centers conducted?

Covenant Health Cancer Centers has 22 clinical trials on record, with 22 currently active. Their work covers Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma.

Is Covenant Health Cancer Centers accredited by Crixeo Health?

Yes — Covenant Health Cancer Centers holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Covenant Health Cancer Centers?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.